Cell Therapy and Tissue Engineering Market Report

Global and Region Cell Therapy and Tissue Engineering Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：226
  • REPORT CODE：GMM945139
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cell Therapy and Tissue Engineering market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cell Therapy and Tissue Engineeringmarket, defines the market attractiveness level of Cell Therapy and Tissue Engineering market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cell Therapy and Tissue Engineering industry, describes the types of Cell Therapy and Tissue Engineering market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cell Therapy and Tissue Engineering market and the development prospects and opportunities of Cell Therapy and Tissue Engineering industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cell Therapy and Tissue Engineering market in Chapter 13.

    By Player:

    • BioReliance Corporation

    • Richter-Helm BioLogics GmbH & Co KG

    • NantKwest Inc

    • ReNeuron Group plc

    • RoosterBio Inc

    • Biosolution Co Ltd

    • Brainstorm Cell Therapeutics Inc

    • Rubius Therapeutics Inc

    • RoslinCT

    • MEDIPOST Co Ltd

    • MolMed SpA

    • Mustang Bio Inc

    • Wuxi App Tec Inc

    • BioCardia Inc

    • WindMIL Therapeutics Inc

    • Betalin Therapeutics

    • Sangamo Therapeutics Inc

    • ReNeuron Group plc

    • Waisman Biomanufacturing

    • Miromatrix Medical Inc

    • Mesoblast Limited

    • RoslinCT

    • NexImmune Inc

    • Voyager Therapeutics Inc

    • Medigene AG

    • RoosterBio Inc

    • Sangamo Therapeutics Inc

    • ReNeuron Group plc

    • Waisman Biomanufacturing

    • Miromatrix Medical Inc

    By Type:

    • Cell Therapy

    • Tissue Engineering

    By End-User:

    • Cell Defects

    • Genetic Diseases

    • Neurodegenerative Diseases

    • Tissue Malignancies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cell Therapy and Tissue Engineering Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cell Therapy and Tissue Engineering Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cell Therapy and Tissue Engineering Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cell Therapy and Tissue Engineering Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cell Therapy and Tissue Engineering Market Analysis and Outlook to 2022

    • 7.1 Global Cell Therapy and Tissue Engineering Consumption (2017-2022)

    • 7.2 United States Cell Therapy and Tissue Engineering Consumption (2017-2022)

    • 7.3 Europe Cell Therapy and Tissue Engineering Consumption (2017-2022)

    • 7.4 China Cell Therapy and Tissue Engineering Consumption (2017-2022)

    • 7.5 Japan Cell Therapy and Tissue Engineering Consumption (2017-2022)

    • 7.6 India Cell Therapy and Tissue Engineering Consumption (2017-2022)

    • 7.7 South Korea Cell Therapy and Tissue Engineering Consumption (2017-2022)

    8 Region and Country-wise Cell Therapy and Tissue Engineering Market Analysis and Outlook to 2028

    • 8.1 Global Cell Therapy and Tissue Engineering Consumption Forecast (2022-2028)

    • 8.2 United States Cell Therapy and Tissue Engineering Consumption Forecast (2022-2028)

    • 8.3 Europe Cell Therapy and Tissue Engineering Consumption Forecast (2022-2028)

    • 8.4 China Cell Therapy and Tissue Engineering Consumption Forecast (2022-2028)

    • 8.5 Japan Cell Therapy and Tissue Engineering Consumption Forecast (2022-2028)

    • 8.6 India Cell Therapy and Tissue Engineering Consumption Forecast (2022-2028)

    • 8.7 South Korea Cell Therapy and Tissue Engineering Consumption Forecast (2022-2028)

    9 Global Cell Therapy and Tissue Engineering Market Outlook by Types and Applications to 2022

    • 9.1 Global Cell Therapy and Tissue Engineering Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cell Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tissue Engineering Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cell Therapy and Tissue Engineering Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cell Defects Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Genetic Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Neurodegenerative Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Tissue Malignancies Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Cell Therapy and Tissue Engineering Market Outlook by Types and Applications to 2028

    • 10.1 Global Cell Therapy and Tissue Engineering Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cell Therapy and Tissue Engineering Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cell Defects Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Genetic Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Neurodegenerative Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Tissue Malignancies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cell Therapy and Tissue Engineering Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cell Therapy and Tissue Engineering Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cell Therapy and Tissue Engineering Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cell Therapy and Tissue Engineering Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cell Therapy and Tissue Engineering Market Competitive Analysis

    • 14.1 BioReliance Corporation

      • 14.1.1 BioReliance Corporation Company Details

      • 14.1.2 BioReliance Corporation Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BioReliance Corporation Cell Therapy and Tissue Engineering Product and Service

    • 14.2 Richter-Helm BioLogics GmbH & Co KG

      • 14.2.1 Richter-Helm BioLogics GmbH & Co KG Company Details

      • 14.2.2 Richter-Helm BioLogics GmbH & Co KG Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Richter-Helm BioLogics GmbH & Co KG Cell Therapy and Tissue Engineering Product and Service

    • 14.3 NantKwest Inc

      • 14.3.1 NantKwest Inc Company Details

      • 14.3.2 NantKwest Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 NantKwest Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.4 ReNeuron Group plc

      • 14.4.1 ReNeuron Group plc Company Details

      • 14.4.2 ReNeuron Group plc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Service

    • 14.5 RoosterBio Inc

      • 14.5.1 RoosterBio Inc Company Details

      • 14.5.2 RoosterBio Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 RoosterBio Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.6 Biosolution Co Ltd

      • 14.6.1 Biosolution Co Ltd Company Details

      • 14.6.2 Biosolution Co Ltd Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Biosolution Co Ltd Cell Therapy and Tissue Engineering Product and Service

    • 14.7 Brainstorm Cell Therapeutics Inc

      • 14.7.1 Brainstorm Cell Therapeutics Inc Company Details

      • 14.7.2 Brainstorm Cell Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Brainstorm Cell Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.8 Rubius Therapeutics Inc

      • 14.8.1 Rubius Therapeutics Inc Company Details

      • 14.8.2 Rubius Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Rubius Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.9 RoslinCT

      • 14.9.1 RoslinCT Company Details

      • 14.9.2 RoslinCT Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 RoslinCT Cell Therapy and Tissue Engineering Product and Service

    • 14.10 MEDIPOST Co Ltd

      • 14.10.1 MEDIPOST Co Ltd Company Details

      • 14.10.2 MEDIPOST Co Ltd Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 MEDIPOST Co Ltd Cell Therapy and Tissue Engineering Product and Service

    • 14.11 MolMed SpA

      • 14.11.1 MolMed SpA Company Details

      • 14.11.2 MolMed SpA Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 MolMed SpA Cell Therapy and Tissue Engineering Product and Service

    • 14.12 Mustang Bio Inc

      • 14.12.1 Mustang Bio Inc Company Details

      • 14.12.2 Mustang Bio Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Mustang Bio Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.13 Wuxi App Tec Inc

      • 14.13.1 Wuxi App Tec Inc Company Details

      • 14.13.2 Wuxi App Tec Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Wuxi App Tec Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.14 BioCardia Inc

      • 14.14.1 BioCardia Inc Company Details

      • 14.14.2 BioCardia Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 BioCardia Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.15 WindMIL Therapeutics Inc

      • 14.15.1 WindMIL Therapeutics Inc Company Details

      • 14.15.2 WindMIL Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 WindMIL Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.16 Betalin Therapeutics

      • 14.16.1 Betalin Therapeutics Company Details

      • 14.16.2 Betalin Therapeutics Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Product and Service

    • 14.17 Sangamo Therapeutics Inc

      • 14.17.1 Sangamo Therapeutics Inc Company Details

      • 14.17.2 Sangamo Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Sangamo Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.18 ReNeuron Group plc

      • 14.18.1 ReNeuron Group plc Company Details

      • 14.18.2 ReNeuron Group plc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Service

    • 14.19 Waisman Biomanufacturing

      • 14.19.1 Waisman Biomanufacturing Company Details

      • 14.19.2 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product and Service

    • 14.20 Miromatrix Medical Inc

      • 14.20.1 Miromatrix Medical Inc Company Details

      • 14.20.2 Miromatrix Medical Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Miromatrix Medical Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.21 Mesoblast Limited

      • 14.21.1 Mesoblast Limited Company Details

      • 14.21.2 Mesoblast Limited Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Mesoblast Limited Cell Therapy and Tissue Engineering Product and Service

    • 14.22 RoslinCT

      • 14.22.1 RoslinCT Company Details

      • 14.22.2 RoslinCT Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 RoslinCT Cell Therapy and Tissue Engineering Product and Service

    • 14.23 NexImmune Inc

      • 14.23.1 NexImmune Inc Company Details

      • 14.23.2 NexImmune Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 NexImmune Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.24 Voyager Therapeutics Inc

      • 14.24.1 Voyager Therapeutics Inc Company Details

      • 14.24.2 Voyager Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Voyager Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.25 Medigene AG

      • 14.25.1 Medigene AG Company Details

      • 14.25.2 Medigene AG Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Medigene AG Cell Therapy and Tissue Engineering Product and Service

    • 14.26 RoosterBio Inc

      • 14.26.1 RoosterBio Inc Company Details

      • 14.26.2 RoosterBio Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 RoosterBio Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.27 Sangamo Therapeutics Inc

      • 14.27.1 Sangamo Therapeutics Inc Company Details

      • 14.27.2 Sangamo Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 Sangamo Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • 14.28 ReNeuron Group plc

      • 14.28.1 ReNeuron Group plc Company Details

      • 14.28.2 ReNeuron Group plc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.28.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Service

    • 14.29 Waisman Biomanufacturing

      • 14.29.1 Waisman Biomanufacturing Company Details

      • 14.29.2 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.29.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product and Service

    • 14.30 Miromatrix Medical Inc

      • 14.30.1 Miromatrix Medical Inc Company Details

      • 14.30.2 Miromatrix Medical Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

      • 14.30.3 Miromatrix Medical Inc Cell Therapy and Tissue Engineering Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cell Therapy and Tissue Engineering

    • Figure Cell Therapy and Tissue Engineering Picture

    • Table Global Cell Therapy and Tissue Engineering Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cell Therapy and Tissue Engineering Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cell Therapy and Tissue Engineering Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cell Therapy and Tissue Engineering Consumption by Country (2017-2022)

    • Figure United States Cell Therapy and Tissue Engineering Consumption and Growth Rate (2017-2022)

    • Table Europe Cell Therapy and Tissue Engineering Consumption and Growth Rate (2017-2022)

    • Figure China Cell Therapy and Tissue Engineering Consumption and Growth Rate (2017-2022)

    • Figure Japan Cell Therapy and Tissue Engineering Consumption and Growth Rate (2017-2022)

    • Figure India Cell Therapy and Tissue Engineering Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cell Therapy and Tissue Engineering Consumption and Growth Rate (2017-2022)

    • Figure Global Cell Therapy and Tissue Engineering Consumption Forecast by Country (2022-2028)

    • Figure United States Cell Therapy and Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cell Therapy and Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cell Therapy and Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cell Therapy and Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cell Therapy and Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cell Therapy and Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Tissue Engineering Consumption and Growth Rate (2017-2022)

    • Figure Global Cell Defects Consumption and Growth Rate (2017-2022)

    • Figure Global Genetic Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Neurodegenerative Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Tissue Malignancies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tissue Engineering Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell Defects Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genetic Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurodegenerative Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tissue Malignancies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cell Therapy and Tissue Engineering Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cell Therapy and Tissue Engineering Export by Region (Top 5 Countries) (2017-2028)

    • Table BioReliance Corporation (Foundation Year, Company Profile and etc.)

    • Table BioReliance Corporation Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioReliance Corporation Cell Therapy and Tissue Engineering Product and Service

    • Table Richter-Helm BioLogics GmbH & Co KG (Foundation Year, Company Profile and etc.)

    • Table Richter-Helm BioLogics GmbH & Co KG Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Richter-Helm BioLogics GmbH & Co KG Cell Therapy and Tissue Engineering Product and Service

    • Table NantKwest Inc (Foundation Year, Company Profile and etc.)

    • Table NantKwest Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table NantKwest Inc Cell Therapy and Tissue Engineering Product and Service

    • Table ReNeuron Group plc (Foundation Year, Company Profile and etc.)

    • Table ReNeuron Group plc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Service

    • Table RoosterBio Inc (Foundation Year, Company Profile and etc.)

    • Table RoosterBio Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table RoosterBio Inc Cell Therapy and Tissue Engineering Product and Service

    • Table Biosolution Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Biosolution Co Ltd Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosolution Co Ltd Cell Therapy and Tissue Engineering Product and Service

    • Table Brainstorm Cell Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Brainstorm Cell Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Brainstorm Cell Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • Table Rubius Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Rubius Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rubius Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • Table RoslinCT (Foundation Year, Company Profile and etc.)

    • Table RoslinCT Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table RoslinCT Cell Therapy and Tissue Engineering Product and Service

    • Table MEDIPOST Co Ltd (Foundation Year, Company Profile and etc.)

    • Table MEDIPOST Co Ltd Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table MEDIPOST Co Ltd Cell Therapy and Tissue Engineering Product and Service

    • Table MolMed SpA (Foundation Year, Company Profile and etc.)

    • Table MolMed SpA Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table MolMed SpA Cell Therapy and Tissue Engineering Product and Service

    • Table Mustang Bio Inc (Foundation Year, Company Profile and etc.)

    • Table Mustang Bio Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mustang Bio Inc Cell Therapy and Tissue Engineering Product and Service

    • Table Wuxi App Tec Inc (Foundation Year, Company Profile and etc.)

    • Table Wuxi App Tec Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wuxi App Tec Inc Cell Therapy and Tissue Engineering Product and Service

    • Table BioCardia Inc (Foundation Year, Company Profile and etc.)

    • Table BioCardia Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCardia Inc Cell Therapy and Tissue Engineering Product and Service

    • Table WindMIL Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table WindMIL Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table WindMIL Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • Table Betalin Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Betalin Therapeutics Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Betalin Therapeutics Cell Therapy and Tissue Engineering Product and Service

    • Table Sangamo Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Sangamo Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • Table ReNeuron Group plc (Foundation Year, Company Profile and etc.)

    • Table ReNeuron Group plc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Service

    • Table Waisman Biomanufacturing (Foundation Year, Company Profile and etc.)

    • Table Waisman Biomanufacturing Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product and Service

    • Table Miromatrix Medical Inc (Foundation Year, Company Profile and etc.)

    • Table Miromatrix Medical Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Miromatrix Medical Inc Cell Therapy and Tissue Engineering Product and Service

    • Table Mesoblast Limited (Foundation Year, Company Profile and etc.)

    • Table Mesoblast Limited Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mesoblast Limited Cell Therapy and Tissue Engineering Product and Service

    • Table RoslinCT (Foundation Year, Company Profile and etc.)

    • Table RoslinCT Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table RoslinCT Cell Therapy and Tissue Engineering Product and Service

    • Table NexImmune Inc (Foundation Year, Company Profile and etc.)

    • Table NexImmune Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table NexImmune Inc Cell Therapy and Tissue Engineering Product and Service

    • Table Voyager Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Voyager Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Voyager Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • Table Medigene AG (Foundation Year, Company Profile and etc.)

    • Table Medigene AG Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medigene AG Cell Therapy and Tissue Engineering Product and Service

    • Table RoosterBio Inc (Foundation Year, Company Profile and etc.)

    • Table RoosterBio Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table RoosterBio Inc Cell Therapy and Tissue Engineering Product and Service

    • Table Sangamo Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Sangamo Therapeutics Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo Therapeutics Inc Cell Therapy and Tissue Engineering Product and Service

    • Table ReNeuron Group plc (Foundation Year, Company Profile and etc.)

    • Table ReNeuron Group plc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Service

    • Table Waisman Biomanufacturing (Foundation Year, Company Profile and etc.)

    • Table Waisman Biomanufacturing Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product and Service

    • Table Miromatrix Medical Inc (Foundation Year, Company Profile and etc.)

    • Table Miromatrix Medical Inc Cell Therapy and Tissue Engineering Sales, Price, Value and Gross Profit (2017-2022)

    • Table Miromatrix Medical Inc Cell Therapy and Tissue Engineering Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US